Type 2 Diabetes clinical trials
391 active trials name this condition (recorded in the registry as “Type 2 Diabetes Mellitus”) . Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- Integrating New Skills Into Diabetes Education With CGM
- Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Exercise and Intranasal Insulin in Type 2 Diabetes
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
- Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- RCT Glargine vs NPH for Treatment of DM in Pregnancy
- Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
- Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
- Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
- Time-restricted Eating for Patients With Type 2 Diabetes
- Mobile App Logging for Diabetes in Pregnancy
- Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
- Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
- Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes
- Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
- Latinos Understanding the Need for Adherence in Diabetes Using E-Health
- A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
- Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
- Personalized Nutrition for Type 2 Diabetes
- Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
- Type 2 Continuous Glucose Monitoring Academy
- DETERMINE: Detemir vs NPH
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
- Project Dulce for Arab Americans With Type 2 Diabetes
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
- Efficacy of Using Mobile Health Applications for Health
- ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
- Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
- Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
- Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Type 2 Diabetes Mellitus” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.